Clindamycin Hydrochloride Capsule — FDA Drug Shortage

To Be Discontinued — Pfizer Inc.

The FDA lists a drug shortage record for Clindamycin Hydrochloride Capsule (capsule) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on Feb 25, 2026.

Shortage details

Status
To Be Discontinued
Company
Pfizer Inc.
Package NDC
0009-0225-02
Dosage Form
Capsule
Presentation
Cleocin Hydrochloride, Capsule, 150 mg (NDC 0009-0225-02)
Initial Posting
Feb 25, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.